We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

JNJ tops second-quarter estimates and raises 2025 guidance as Innovative Medicines outperforms and MedTech gains momentum.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Raritan: Johnson & Johnson has received priority review from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) filed for TAR-200, an intravesical gemcitabine ...

Stay updated on Johnson & Johnson's Q2 earnings as it faces tariff threats, MedTech challenges, and legal risks.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Johnson & Johnson (NYSE: JNJ) ranks among the best forever stocks to invest in. Prior to the company’s second-quarter ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Johnson & Johnson (JNJ) has reportedly revised its forecast of the impact of U.S. President Donald Trump’s tariffs to $200 ...

Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research ...